Karo Pharma
Drug Stores & Pharmacies · Belgium · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Mont De Solre 24, Erquelinnes, Wallonia,...Phone Number
+32 71555029Website
www.karopharma.comRevenue
$338.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. The company own and commercialize branded, original over-the-counter products and prescription medicines. The company's products are available in more than 90 countries, with Europe and the Nordic region as the company's core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq First North Growth Market.Explore more
Popular SearchesKaro Pharma ABKaro PharmaCaro PharmaKaro Press VofKaro Pharma AsSIC Code 51,512NAICS Code 42,424Show moreKaro Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Karo Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Karo Pharma has new funding data
Check out if Karo Pharma is spiking on competitors!
Karo Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Karo Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Karo Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Karo Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Karo Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Karo Pharma had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Karo Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Karo Pharma is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Karo Pharma is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Karo Pharma.
Karo Pharma Tech Stack
A closer look at the technologies used by Karo Pharma
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
New Hire
Executive Move
New Hire
New Hire
Executive Move
Karo Pharma News & Media
Karo Pharma Aktiebolag’s application for de-listing has been approved
Karo Pharma Aktiebolag’s (“Karo Pharma” or the “Company”) application for de-listing has now been approved by Nasdaq. The last day of trading in Karo Pharma’s share on Nasdaq First North Growth Market will be 24 November 2022. As previously announced, Karo Pharma has applied for de-listing of the Company’s shares from Nasdaq First North Growth Market. Nasdaq has now approved the application and resolved that the last day of trading will be 24 November 2022.Karo Pharma Aktiebolag applies for de-listing
The Board of Directors of Karo Pharma Aktiebolag (“Karo Pharma” or the “Company”) has resolved to apply for de-listing of the Company’s shares from Nasdaq First North Growth Market following that Karo Intressenter AB[1] (“Karo Intressenter”) controls more than 90 percent of the shares in Karo Pharma and has initiated compulsory redemption of the remaining shares in the Company On 16 August 2022, Karo Intressenter announced a public cash offer to the shareholders in KaroKaro Intressenter AB announces outcome of the extended acceptance period of the public cash offer to the shareholders in Karo Pharma Aktiebolag and extends the acceptance period one last time
The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws orKaro Intressenter AB announces outcome of the extended acceptance period of the public cash offer to the shareholders in Karo Pharma Aktiebolag and further extends the acceptance period
The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Karo Pharma
Sign Up For FreeTo access detailed company insights
Karo Pharma delivers smart choices for everyday healthcare. The company own and commercialize branded, original over-the-counter products and prescription medicines. The company's products are available in more than 90 countries, with Europe and the Nordic region as the company's core markets. Karo Pharma is headquartered in Stockholm, Sweden and l... Read More
